Keywords: sankyo, profits, rise, mevalotin, sales, strong, japanese
Sankyo's Profits Rise on Mevalotin Sales
Article | 28 November 1994
Strong sales of Japanese pharmaceutical company Sankyo's lipid-lowering agent Mevalotin (pravastatin) drove the company's profits higher in the first six ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
